您当前的位置:首页 > 《麻醉与监护论坛》杂志文章 > 17卷第1期
摘要 目的 检测脓毒症患者外周血中CD4+CD25+ Treg的比例(Treg%)变化,并探讨它和患者细胞免疫紊乱之间的关系。方法 收集ICU病房的脓毒症患者为病例组(n=27),健康查体者为对照组(n=40)。将脓毒症患者根据28天预后分为死亡组(n=8)和存活组(n=19)。监测APACHEⅡ评分、Treg%、CD3%、CD4/CD8, Ag-NORs数量(IS%)等。以上指标各组进行比较,统计分析。结果 和对照组相比,病例组Treg%明显升高,CD3%、CD4/CD8、IS%明显下降,均有显著统计学意义(P<0.001)。行相关分析发现脓毒症患者的Treg%和CD4/CD8,IS%呈负相关,分别有r=- -0.484(P<0.01)及r=-0.588(P<0.01)。同样发现,死亡组和存活组相比,前者Treg%明显升高(P<0.001),CD3%、CD4/CD8、IS%明显下降(分别有P<0.001、 P<0.05、 P<0.001)。结论 脓毒症患者早期就有CD4+CD25+ Treg的明显升高,并发生细胞免疫紊乱,因CD3%、CD4/CD8、IS%明显下降,升高的CD4+CD25+ Treg通过一定途径参与细胞免疫功能紊乱的发生。 关键词: 脓毒症 ;调节细胞;细胞免疫 责任作者及联系方式: 张丽娜; E-mail:zln_109@126.com The relationship between the level of CD4+CD25+ Treg and cell immunity in patients with sepsis ZHANG Li-na ,WU Tie-jun,LIU zhi-jun. Intensive Care Unit,Liaocheng People’s Hospital. Abstract Objective To investigate the percentage of CD4+CD25+ Treg in peripheral blood of patients with sepsis and explore its effect on cell immunity. Metheds select patients with sepsis in ICU as case group(n=27), healthy volunteers were enrolled as control group(n=40)。Devied the sepsis patients into death group and survival group depend on the outcome after 28 days .Detect APACHEⅡscore、Treg%、CD3%、CD4/CD8、IS% etc.Compared between assosiated groups . Progressed statistical analysis. Results Compared with the control group , the percentage of CD4+CD25+ Treg was significant higher and the CD3%、CD4/CD8、IS% were significant lower in case group ,all had significant statistics significance(P <0.001). Correlation analysis indicated that Treg%had negative correlation with CD4/CD8、IS%(P<0.01).Samely, Compared with the survival group , the percentage of CD4+CD25+ Treg was significant higher(P<0.001) and the CD3%、CD4/CD8、IS% were significant lower(P<0.001、 P<0.05、 P<0.001) in death grou p .Conlusion The percent of CD4+CD25+ Treg was significent higher and CD3%、CD4/CD8、IS% were lower which indected cell immunity disorder even in the earlier period of sepsis . The CD4+CD25+ Treg produced a marked effect on the development of cell immunity disorder. Key words: Sepsis ;Regulatory cells;cell immunity Corresponding author: ZHANG Li-na, E-mail:zln_109@126.com 脓毒症是临床危重病患者主要死亡原因之一,在美国每年约有54万脓毒症患者,其中21.5万患者终因脓毒症而死亡【1】。近年来,人们对脓毒症的发病机制及发病过程有了更深的了解,大量研究表明脓毒症患者可发生严重的免疫功能紊乱,尤其是免疫功能低下,这也是导致脓毒症患者死亡的重要原因,但是其具体机制尚不明了。因此深入探讨脓毒症患者免疫紊乱发生的参与因素具有重大的临床意义。CD4+CD25+ Treg细胞是近年来新发现的一种负向免疫调节细胞,它可以通过许多途径影响机体的免疫状态。本文通过研究脓毒症患者外周血中CD4+CD25+ Treg及细胞免疫学指标CD3%、CD4/CD8、IS%的变化特点,来探讨CD4+CD25+ Treg对脓毒症患者细胞免疫的影响。 1 资料与方法 1.1 研究对象: 选择2007年8月~2008年8月入住我院ICU的脓毒症患者27例,均符合2001年12月在美国华盛顿召开的国际脓毒症定义会议所制定的脓毒症诊断标准【2】。其中肠破裂、肠坏死术后14例,感染休克5例,胆囊坏死切除术后4例,会阴感染1例,宫腔感染3例。所有患者均无自身免疫性疾病病史,无恶性肿瘤,近期未应用过免疫性药物。健康对照组40例,均选自本院健康查体者,年龄、性别构成较对照组均无明显差异。 1.2 监测指标: 于诊断成立后的24小时内无菌抗凝抽取静脉血2ml,2小时内应用流式细胞仪技术(FCM)进行外周血Treg%、CD3%、 CD4/CD8的检测。同时取无菌抗凝血0.3-0.5ml加入T淋巴细胞培养液中, 1.3 统计学方法: 全部数据采用SAS6.12 统计软件进行统计分析,所有数据采用均数±标准差( |